Transjugular intrahepatic portosystemic shunt in the management of refractory ascites

Seminars in Interventional Radiology

Volumn 22, Issue 4, 2005, Pages 278-286

  Garcia Tsao, Guadalupe ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; Large volume paracentesis; Refractory ascites; Transjugular intrahepatic portosystemic shunt

Indexed keywords

POLITEF; RENIN;

ASCITES; HEALTH CARE COST; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER SINUSOID; PARACENTESIS; PLASMA RENIN ACTIVITY; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; SODIUM EXCRETION; SURVIVAL;

EID: 30344455582     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-925554     Document Type: Review

References (56)

1. Loureiro-Silva MR, Cadelina GW, Groszmann RJ. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Am J Physiol Gastrointest Liver Physiol 2003;284:G567-G574
2. Rector WG. Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding. Liver 1986;6:221-226
3. Morali GA, Sniderman KW, Deitel KM, et al. Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites? J Hepatol 1992;16:249-250
4. Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647-655
5. Abraldes JG, Tarantino I, Turnes J, et al. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003;37:902-908
6. Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-1157
7. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-176
8. Salerno F, Borroni G, Moser P, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993;88:514-519
9. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: consensus conference of the International Ascites Club. Hepatology 2003;38:258-266
10. Gines A, Fernandez-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran-70 and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996;111:1002-1010
11. Ruiz del Arbol L, Monescillo A, Jimenez W, et al. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997;113:579-586
12. Gines P, Arroyo V, Vargas V, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991;325:829-835
13. Gines A, Planas R, Angeli P, et al. Treatment of patients with cirrhosis and refractory ascites by LeVeen shunt with titanium tip. Comparison with therapeutic paracentesis. Hepatology 1995;22:124-131
14. Castells A, Salo J, Planas R, et al. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study. Hepatology 1994;20:584-591
15. Voorhees ABJ, Price JBJ, Britton RC. Portasystemic shunting procedures for portal hypertension: twenty-six year experience in adults with cirrhosis of the liver. Am J Surg 1970;119:501-505
16. Orloff MJ, Orloff MS, Orloff SL, et al. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites. J Am Coll Surg 1997;184:557-570
17. Franco D, Vons C, Traynor O, et al. Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis? Arch Surg 1988;123:987-991
18. Luca A, D'Amico G, LaGalla R, et al. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999;212:411-421
19. Wong F, Sniderman K, Liu P, et al. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995;122:816-822
20. Wong F, Sniderman K, Liu P, et al. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 1997;112:899-907
21. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts-comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996;25:135-144
22. Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995;21:986-994
23. Gerbes AL, Gulberg V, Waggershauser T, et al. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites or without ascites. Hepatology 1998;28:683-688
24. Wong W, Liu P, Blendis L, et al. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites. Am J Med 1999;106:315-322
25. Somberg KA, Lake JR, Tomlanovich SJ, et al. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995;21:709-716
26. Ferral H, Bjarnason H, Wegryn SA, et al. Refractory ascites: early experience with transjugular intrahepatic portosystemic shunt. Radiology 1993;189:795-801
27. Russo MW, Sood A, Jacobson IM, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality. Am J Gastroenterol 2003;98:2521-2527
28. Garcia-Tsao G.Transjugular intrahepatic portosystemic shunt for the management of refractory ascites in cirrhosis. In: Gines P, Arroyo V, Rodes J, Schrier RW, eds. Ascites and Renal Dysfunction in Liver Disease. 2nd edition. Oxford: Blackwell Publishing; 2005:251-259
29. Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701-1707
30. Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus repeated paracentesis plus intravenous albumin for refractory ascites in cirrhosis: a multicenter randomized comparative study. Gastroenterology 2002;123:1839-1847
31. Sanyal AJ, Genning C, Reddy KR, et al. The North American Study for the treatment of refractory ascites. Gastroenterology 2003;124:634-641
32. Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004;40:629-635
33. Arroyo V, Rodes J, Gutierrez Lizarraga MA, et al. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis 1976;21:249-256
34. Llach J, Gines P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal fonction in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988;94:482-487
35. Schepke M, Roth F, Koch L, et al. Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleeding. Digestion 2003;67:146-153
36. Saab S, Nieto J, Ly D, et al. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev 2004;3:CD004889
37. Deltenre P, Mathurin P, Dharancy S, et al. Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis. Liver Int 2005;25:349-356
38. Gulberg V, Liss I, Bilzer M, et al. Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts. Digestion 2002;66:127-130
39. Bureau G, Garcia-Pagan JC, Otal P, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004;126:469-475
40. Angermayr B, Cejna M, Koenig F, et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology 2003;38:1043-1050
41. Rosemurgy AS, Zervos EE, Clark WC, et al. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial. Ann Surg 2004;239:883-889
42. Trotter JF, Suhocki PV. Incarceration of umbilical hernia following transjugular intrahepatic portosystemic shunt for the treatment of ascites. Liver Transpl Surg 1999;5:209-210
43. Riggio O, Masini A, Efrati C, et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol 2005;42:674-679
44. Banares R, Nunez O, Escudero M, et al. Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma. Hepatology 2005;41:566-571
45. Martinet JP, Fenyves D, Legault L, et al. Treatment of refractory ascites using TIPS: a caution. Dig Dis Sci 1997;42:161-166
46. Casado M, Bosch J, Garcia-Pagan JC, et al. Clinical events following transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998;114:1296-1303
47. Riggio O, Merli M, Pedretti G, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: incidence and risk factors. Dig Dis Sci 1996;41:578-584
48. Crenshaw WB, Gordon FD, McEniff NJ, et al. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996;200:185-192
49. Nazarian GK, Bjarnason H, Dietz CAJ, et al. Refractory ascites: results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997;205:173-180
50. Besehenes M, Dufresne MP, Bui B, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999;94:1361-1365
51. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-1197
52. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871
53. Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002;36:494-500
54. Schepke M, Roth F, Fimmers R, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003;98:1167-1174
55. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003;52:879-885
56. Membreno F, Baez AL, Pandula R, et al. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. J Gastroenterol Hepatol 2005;20:474-481